Chemistry World: More Than a Mirror-Image: Left-Handed Nucleic Acids

Two double helixes of DNA, one appears normal and the other appears jagged and damaged.
February 20, 2024
The Division of Pharmacology & Toxicology's Karen Vasquez, Ph.D. talked to Chemistry World's Rachel Brazil on genetic instability in disease and evolution of course related to Z-DNA. Dr. Vasquez's research focuses on genome instability, DNA damage and mechanisms of repair.

Moczygemba and Janzen Earn Promotions

Two women smiling while both wear dark clothing.
February 27, 2023
Two of the college's distinguished faculty in the Division of Health Outcomes and Division of Pharmacy Practice were recommended for promotion by President Hartzell due to their outstanding accomplishments in research, outreach and education. Dr. Tish Moczygemba will assume the rank of professor and Dr. Kristin Janzen will become a clinical associate professor.

Vasquez Writes in Nature Reviews Genetics on Alternative DNA Structures

"Nature Reviews Genetics" written inside of a circle.
November 1, 2022
Division Head and Professor of Pharmacology & Toxicology Karen Vasquez, Ph.D. published in the latest issues of Nature Reviews Genetics regarding repetitive elements in the human genome. Once considered "junk DNA," they are now known to adopt more than a dozen alternative DNA structures. These dynamic conformations can act as functional genomic elements involved in DNA replication and transcription, chromatin organization and genome stability.

Faculty Earn State Grants for Cancer Research

A person in a lab.
September 21, 2022
The Cancer Prevention and Research Institute of Texas (CPRIT) has released its grant research funding awards for the upcoming year. All three awarded research projects at The University of Texas at Austin involve College of Pharmacy faculty.

Summer Programs of Innovation and Diversity

LEADER/PEPP Program participants and leaders sitting together at an outdoor table for lunch.
September 6, 2022
This summer, the office of Diversity, Equity, Accessibility, and Inclusion (DEAI), hosted two intensive summer research programs: Project Engage Pharmacy Program (PEPP) Camp and the Leadership Through Engagement For the Advancement of Diverse Educational Research (LEADER) Program.

PharmE3D Labs Earn National and International Accolades

Brick facade of Pharmacy building with affixed text, "The University of Texas at Austin College of Pharmacy"
July 11, 2022
Researchers in UT Pharmacy's Pharmaceutical Engineering and 3D Printing (PharmE3D) Labs have earned a bevy of national and international awards for their work in pharmaceutical drug delivery and 3D printing personalized medicines.

PharmE3D Labs Receive Federal Funding for 3D Printed Contraception

Four people wearing masks and lab coats.
March 14, 2022
Dr. Mo Maniruzzaman's Pharmaceutical Engineering and 3D Printing Labs have received a federal grant from the United States Agency for International Development (USAID) to develop personalized 3D printed non-hormonal intrauterine devices (IUDs). The project’s goal is to increase global access to long-term and effective contraception while minimizing some of its most debilitating side effects.

PharmE3D Labs Receive R01 Grant for Complex Vaccine Technologies

Three people smiling.
September 24, 2021
The College of Pharmacy’s Pharmaceutical Engineering and 3D Printing (PharmE3D) Labs recently earned a three-year $1.5 million National Institutes of Health (NIH) R01 grant to research novel manufacturing technology for complex vaccine formulations for influenza and other emerging infectious diseases.

PharmE3D Labs Earn Multiple Pharmaceutical Science Distinctions

Three men smiling.
September 10, 2021
The college's Pharmaceutical Engineering and 3D Printing (PharmE3D) labs, led by Assistant Professor in Molecular Pharmaceutics and Drug Delivery Mohammed (Mo) Maniruzzaman, Ph.D., has recently earned several national and international awards and scholarships for outstanding research contributions to the field of pharmaceutical science and technology.

Research Provides Further Insight into Causes of Manganese-Induced Parkinsonism

A man smiling in a research lab.
September 7, 2021
Somshuvra Mukhopadhyay, M.B.B.S., Ph.D., associate professor in the Division of Pharmacology and Toxicology and Hamm Centennial Fellow in Pharmacy, and a team of researchers have released new findings defining the first homeostatic regulatory pathway for manganese in mammalian systems. Identifying these pathways opens up new possible options to prevent or treat manganese-induced parkinsonism and other disorders linked to elevated manganese exposure.